Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-Year follow-up results

American Journal of Rhinology and Allergy

Volumn 24, Issue 4, 2010, Pages 271-275

  Kim, Seung Tae ^a   Han, Doo Hee ^a   Moon, Il Joon ^a   Lee, Chul Hee ^a,b   Min, Yang Gi ^a   Rhee, Chae Seo ^a,b  

^a Seoul National University   (South Korea)

^b Natl Creative Res Initiatives C   (South Korea)

Author keywords

Allergic rhinitis; Asian; Dermatophagoides farinae; Dermatophagoides pteronyssinus; Efficacy; Eosinophil cationic protein; House dust mites; Patient selection; Sublingual immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; PANGRAMIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; BLOOD; BREATHING DISORDER; CHILD; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DRUG DOSE INCREASE; DRUG EFFICACY; EOSINOPHIL COUNT; EYE DISCOMFORT; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LIP PRURITUS; MAJOR CLINICAL STUDY; MALE; MOUTH PRURITUS; NASAL PRURITUS; NOSE OBSTRUCTION; PRESCHOOL CHILD; PRURITUS; RASH; RHINORRHEA; SCHOOL CHILD; SLEEP DISORDER; SMELLING DISORDER; SNEEZING; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; TREATMENT RESPONSE; WHEEZING;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CELL COUNT; CHILD; DESENSITIZATION, IMMUNOLOGIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; MIDDLE AGED; PYROGLYPHIDAE; REPUBLIC OF KOREA; RHINITIS, ALLERGIC, PERENNIAL;

EID: 77955607935     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3501     Document Type: Article

References (26)

1. Bousquet J, and Michel F. Immunotherapy in rhinitis. Mygind N and Naclerio R, (eds.). Copenhagen: Munksgard, 1992.
2. Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 302:265-269, 1991.
3. Reid MJ, Lockey RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 92:6-15, 1993.
4. Saporta D. Sublingual immunotherapy: A novel, albeit not so new, immunotherapy treatment modality. Am J Rhinol 22:253-257, 2008.
5. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
6. Compalati E, Passalacqua G, Bonini M, et al. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: Results of a GA(2)LEN meta-analysis. Allergy 64:1570-1579, 2009.
7. Chang H, Han DH, Mo JH, et al. Early compliance and efficacy of sublingual immunotherapy in patients with allergic rhinitis for house dust mites. Clin Exp Otorhinolaryngol 2:136-140, 2009.
8. Di Lorenzo G, Mansueto P, Pacor ML, et al. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. J Allergy Clin Immunol 123:1103-1110, 2009.
9. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 62:317-324, 2007.
10. Passalacqua G, Pasquali M, Ariano R, et al. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 61:849-854, 2006.
11. Guez S, Vatrinet C, Fadel R, et al. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: A double-blind, placebo-controlled study. Allergy 55:369-375, 2000.
12. Tonnel AB, Scherpereel A, Douay B, et al. Allergic rhinitis due to house dust mites: Evaluation of the efficacy of specific sublingual immunotherapy. Allergy 59:491-497, 2004.
13. Lue KH, Lin YH, Sun HL, et al. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: A double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 17:408-415, 2006.
14. Hirsch T, Sahn M, and Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 8:21-27, 1997.
15. Larenas-Linnemann DE. Sublingual immunotherapy: Dosing in relation to clinical and immunological efficacy. Allergy Asthma Proc 29:130-139, 2008.
16. Bahceciler NN, Arikan C, Taylor A, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int Arch Allergy Immunol 136:287-294, 2005.
17. Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 351:629-632, 1998.
18. Marcucci F, Sensi L, Frati F, et al. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): Safety and immunologic implications. Allergy 56:1091-1095, 2001.
19. Tahamiler R, Saritzali G, and Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope 117:965-969, 2007.
20. Smith H, White P, Annila I, et al. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 114:831-837, 2004.
21. de Groot H, and Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 64:963-964, 2009.
22. Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 63:374, 2008.
23. Dunsky EH, Goldstein MF, Dvorin DJ, et al. Anaphylaxis to sublingual immunotherapy. Allergy 61:1235, 2006.
24. Eifan AO, Keles S, Bahceciler NN, et al. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 62:567-568, 2007.
25. Antico A, Pagani M, and Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 61:1236-1237, 2006.
26. Frew AJ. Sublingual immunotherapy. N Engl J Med 358:2259-2264, 2008.